Long term complications after completion of pulmonary tuberculosis treatment: A quest for a public health approach

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Volumn 3, Issue , 2016, Pages 10-12

  Chakaya, Jeremiah ^a   Kirenga, Bruce ^b   Getahun, Haileyesus ^c  

^a KENYATTA UNIVERSITY   (Kenya)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Complications; Public health; Pulmonary tuberculosis

Indexed keywords

EID: 84962330808     PISSN: None     EISSN: 24055794     Source Type: Journal    
DOI: 10.1016/j.jctube.2016.03.001     Document Type: Editorial

References (31)

1. WHO, Global Tuberculosis Report 2015.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Internal Med 2003, 163(9):1009-1021. 10.1001/archinte.163.9.1009.
3. Lawn SD, Churchyard G Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009, 4(4):325-333. 10.1097/COH.0b013e32832c7d61.
4. Wilkinson D, Davies GR The increasing burden of tuberculosis in rural South Africa-impact of the HIV epidemic. S Afr Med J 1997, 87(4):447-450.
5. Maher D, Harries A, Getahun H, Maher D, Harries A, Getahun H Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health 2005, 10(8):734-742.
6. Dooley KE, Chaisson RE Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746. 10.1016/S1473-3099(09)70282-8.
7. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJAM, van Crevel R Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Intern Health 2010, 15:1289-1299.
8. Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011, 15:1436-1444. 10.5588/ijtld.11.0503.
9. Long R, Maycher B, Manfreda J, et al. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest 1998, 113:933-943.
10. Hoger S, Miller T, Katz D, Beavers S, et al. Longevity loss among cured tuberculosis patients and the potential value of prevention. Int J Tuberc Lung Dis 2014, 18:1347-1352.
11. Rajeswari R, Muniyandi M, Balasubramanian R, Naryanan P.R. Perceptions of tuberculosis patients about their physical, menal and social wellbeing: a field report from South India. Soc Sci Med 2005, 60:1845-1853.
12. Rekha BVV, Ramachandran R, Rao KVK, Rahman F, Adhilakshmi AR, Kalaiselvi D, et al. Assessment of long term status of sputum positive pulmonary tb patients successfully treated with short course chemotherapy. Indian J Tuberc 2009, 56:132-140.
13. Lam KH, Jiang CQ, Jordan R, Miller MR, Zhang WS, Cheng KK, et al. Prior tuberculosis, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort study. Chest 2010, 137:593-600.
14. Ross J, Ehlrich R, Hnizdo E Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax 2010, 65:1010-1015.
15. Shah M, Reed C Complications of tuberculosis. Curr Opin Infect Dis 2014, 27(5):403-410.
16. Liang Hui-Ying, Li Xue-Lian, Yu Xiao-Song, Guan Peng, Yin Zhi-Hua, He Qin-Cheng, et al. Facts and Fiction of the relationship between pre-existing tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009, 125:2936-2944.
17. Singla Neeta, Singla Rupak, Fernandes Sheron, Behera Digamber Post treatment sequelae of multidrug resistant tuberculosis patients. Indian J Tuberc 2009, 56(4):206-212.
18. Long R, Maycher B, Manfreda J, et al. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest 1998, 113:933-943.
19. Gordon L.Snider, Leroy Doctor, Theodore A Demas, Allan R Shaw Am Rev Respir Dis 1971, 103(5):625-640.
20. Wilcox PA, Ferguson AD chronic obstructive airways disease following treated pulmonary TB. Respir Med 1989, 83:195-198.
21. Hnzido E, Singh T, Churchyard G Chronic Pulmonary function impairment by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000, 55:32-38.
22. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE Pulmonary impairment after tuberculosis. Chest 2007, 131(6):1817-1824.
23. Menezes AM, Perez âPadilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the Platino study): a prevalence study. Lancet 2005, 366:1875-1881.
24. Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis 2015, 32:138-146.
25. Amaral AndréF.S., Coton Sonia, Kato Bernet, Tan WanC., Studnicka Michael, Janson Christer, et al. For the BOLD collaborative research group lung function defects in treated pulmonary tuberculosis patients. Eur Respir J 2016, 47(1):352-353.
26. Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C Eur Respir J 2016, 47(1):352-353.
27. Jordan ToniS., Spencer ElspethM., Davies Peter Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010, 15:623-628.
28. Denning DW, Pleuvry A, Cole DC Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011, 89(12):864-872.
29. Agarwal R, Vishwanath G, Aggarwal AN, Garg M, Gupta Chakrabarti A Itraconazole in chronic cavitary aspergillosis: a randomized controlled trial and systematic review of literature. Mycoses 2013, 56(5):559-570.
30. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's GlobalTB programme. WHO's end TB strategy. Lancet 2015, 385(9979):1799-1801.
31. Practical Approach to Lung Health (PAL). A primary health care strategy for the integrated management of respiratory conditions in people five years of age and over. WHO/HTM/TB/2005.351. http://www.who.int/tb/publications/pal-primary-strategy/en/.